Pre-test score | Post-test score | ||||
---|---|---|---|---|---|
Variable | Category | Frequency n (%) | Mean (Standard deviation) | Mean (Standard deviation) | p- value |
Epidemiology and Transmission | |||||
Gender | Male | 20 (45.5%) | 9.0 (1.5) | 9.4(0.9) | 0.05 |
Female | 24 (54.5%) | 8.2 (1.8) | 9.5 (0.7) | 0.001 | |
Age (years) | ≤ 30 | 22 (50.0%) | 8.5 (1.5) | 9.3 (0.6) | 0.008 |
> 30 | 22 (50.0%) | 8.5 (1.9) | 9.5 (0.9) | 0.007 | |
Duration in service (years) | ≤ 5 | 24 (54.5%) | 8.8 (1.5) | 9.5 (0.8) | 0.008 |
> 5 | 20 (45.5%) | 8.2 (1.8) | 9.4 (0.8) | 0.006 | |
Health facility | Arua | 28 (64.0%) | 8.6 (1.5) | 9.4 (0.8) | 0.016 |
Koboko | 16 (36.0%) | 8.4 (1.8) | 9.6 (0.8) | 0.002 | |
Natural history of HBV | |||||
Gender | Male | 20 (45.5%) | 4.5 (1.5) | 5.2 (1.5) | 0.131 |
Female | 24 (54.5%) | 3.6 (1.9) | 4.3 (1.7) | 0.046 | |
Age (years) | ≤ 30 | 22 (50.0%) | 4.0 (1.6) | 4.2 (1.4) | 0.535 |
> 30 | 22 (50.0%) | 4.0 (1.9) | 5.2 (1.7) | 0.004 | |
Duration in service (years) | ≤ 5 | 24 (54.5%) | 4.0 (1.6) | 4.7 (1.7) | 0.044 |
> 5 | 20 (45.5%) | 4.1 (1.9) | 4.7 (1.6) | 0.124 | |
Health facility | Arua | 28 (64.0%) | 3.8 (1.9) | 4.7 (1.8) | 0.008 |
Koboko | 16 (36.0%) | 4.4 (1.4) | 4.6 (1.5) | 0.628 | |
Diagnosis of HBV | |||||
Gender | Male | 20 (45.5%) | 2.9 (1.3) | 3.0 (1.2) | 0.649 |
Female | 24 (54.5%) | 2.0 (0.9) | 2.1 (1.1) | 0.869 | |
Age (years) | ≤ 30 | 22 (50.0%) | 2.1 (1.0) | 2.7 (1.2) | 0.589 |
> 30 | 22 (50.0%) | 2.7 (1.2) | 2.7 (1.3) | 1.000 | |
Duration in service (years) | ≤ 5 | 24 (54.5%) | 2.5 (1.1) | 2.7 (1.3) | 0.462 |
> 5 | 20 (45.5%) | 2.4 (1.1) | 2.3 (1.2) | 0.847 | |
Health facility | Arua | 28 (64.0%) | 2.3 (1.1) | 2.5 (1.2) | 0.312 |
Koboko | 16 (36.0%) | 2.4 (1.2) | 2.6 (1.3) | 0.509 | |
Treatment of HBV | |||||
Gender | Male | 20 (45.5%) | 6.1 (1.4) | 7.2 (1.0) | 0.001 |
Female | 24 (54.5%) | 4.9 (1.4) | 6.8 (1.2) | < 0.001 | |
Age (years) | ≤ 30 | 22 (50.0%) | 5.3 (1.8) | 6.9 (1.2) | < 0.001 |
> 30 | 22 (50.0%) | 5.6 (1.3) | 7.1 (1.1) | < 0.001 | |
Duration in service (years) | ≤ 5 | 24 (54.5%) | 5.7 (1.5) | 6.9 (1.3) | 0.001 |
> 5 | 20 (45.5%) | 5.1 (1.6) | 7.1 (0.9) | < 0.001 | |
Health facility | Arua | 28 (64.0%) | 5.2 (1.5) | 7.1 (1.1) | < 0.001 |
Koboko | 16 (36.0%) | 7.1 (1.1) | 6.8 (1.2) | < 0.001 | |
Prevention of HBV | |||||
Gender | Male | 20 (45.5%) | 4.3 (1.2) | 4.3 (0.9) | 0.825 |
Female | 24 (54.5%) | 4.2 (1.0) | 3.9 (1.0) | 0.397 | |
Age (years) | ≤ 30 | 22 (50.0%) | 4.0 (1.0) | 4.1 (1.0) | 0.880 |
> 30 | 22 (50.0%) | 4.4 (1.1) | 4.0 (0.8) | 0.088 | |
Duration in service (years) | ≤ 5 | 24 (54.5%) | 4.3 (1.0) | 4.1 (0.9) | 0.632 |
> 5 | 20 (45.5%) | 4.2 (1.1) | 4.0 (0.8) | 0.447 | |
Health facility | Arua | 28 (64.0%) | 4.0 (1.1) | 4.1 (0.8) | 0.526 |
Koboko | 16 (36.0%) | 4.6 (0.9) | 3.9 (1.1) | 0.022 |